Novartis now offers many associates the choice to decide how, where and when they work* to create the greatest impact for their role while taking personal responsibility to inform managers and align with teammates for effective collaboration, based on the nature of their work.
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
Novartis researchers aim to quash inflammation to treat chronic disease.
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
Novartis announced the company’s financial results for the second quarter and first half of 2020.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.